"A Phase 2 Study of Nivolumab for High-Risk Oral Leukoplakia." by Alessandro Villa

Selected Works of Alessandro Villa

Follow Contact

Article

A Phase 2 Study of Nivolumab for High-Risk Oral Leukoplakia.

Annals of Oncology (2022)

Alessandro Villa, Baptist Health South Florida
G.J. Hanna, Harvard University
R. Shi
A. ONeill
M. Liu
C. T. Quinn
R. K. Curtin
M. Flynn
N. S. Treister
H. Y. Sroussi
P. Vacharotayangul
Laura A Goguen, Brigham and Women's Hospital
D. J. Annino
E. Rettig
Jo Vy
K. Wong
R. Uppaluri, Brigham and Women's Hospital
R. I. Haddad
S. B. Woo

Link

Keywords

Nivolumab,
Oral Leukoplakia

Disciplines

Medicine and Health Sciences

Publication Date

August, 2022

Citation Information

Alessandro Villa, G.J. Hanna, R. Shi, A. ONeill, et al.. "A Phase 2 Study of Nivolumab for High-Risk Oral Leukoplakia." Annals of Oncology Vol. 33 Iss. 7 (2022) p. S295 - S322 ISSN: 0923-7534
Available at: http://works.bepress.com/alessandro-villa/1/